{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:55:07Z","timestamp":1787068507683,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bioorg.2019.103557","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T19:52:57Z","timestamp":1577389977000},"page":"103557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents"],"prefix":"10.1016","volume":"95","author":[{"given":"Soumajit","family":"Ghorai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravani","family":"Pulya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathi","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shovanlal","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103557_b0005","first-page":"887","article-title":"Glaucoma is second leading cause of blindness globally","volume":"82","author":"Kingman","year":"2004","journal-title":"Bulletin World Health Org."},{"key":"10.1016\/j.bioorg.2019.103557_b0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.pop.2015.05.008","article-title":"Glaucoma","volume":"42","author":"Mantravadi","year":"2015","journal-title":"Primary Care: Clinics in Office Practice."},{"key":"10.1016\/j.bioorg.2019.103557_b0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd3745","article-title":"Ophthalmic drug discovery: novel targets and mechanisms for retinal disease and glaucoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103557_b0020","unstructured":"https:\/\/nei.nih.gov\/news\/pressreleases\/012114 (acess on 26\/12\/2018)."},{"key":"10.1016\/j.bioorg.2019.103557_b0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/13543776.2012.649006","article-title":"Novel therapies for glaucoma: a patent review 2007\u20132011","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2019.103557_b0030","series-title":"Antiglaucoma Carbonic Anhydrase Inhibitors as Ophthalomologic Drugs","first-page":"139","author":"Mincione","year":"2009"},{"key":"10.1016\/j.bioorg.2019.103557_b0035","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2019.103557_b0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bioorg.2019.103557_b0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ml500140t","article-title":"Carbonic anhydrase inhibitors: design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives","volume":"5","author":"Pichake","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103557_b0050","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2019.103557_b0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/OPTH.S15971","article-title":"Novel ocular antihypertensive compounds in clinical trials","volume":"5","author":"Chen","year":"2011","journal-title":"Clin. Ophthalmol. (Auckland, N.Z.)"},{"key":"10.1016\/j.bioorg.2019.103557_b0060","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1167\/iovs.06-0830","article-title":"Aqueous humor outflow: what do we know? Where will it lead us?","volume":"47","author":"Fautsch","year":"2006","journal-title":"Invest Ophthalmol. Visual Science."},{"key":"10.1016\/j.bioorg.2019.103557_b0065","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.exer.2008.12.012","article-title":"Uveoscleral outflow - a review","volume":"88","author":"Alm","year":"2009","journal-title":"Experim. Eye Res."},{"key":"10.1016\/j.bioorg.2019.103557_b0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/17460441.2015.1000857","article-title":"Discovery of novel inhibitors for the treatment of glaucoma","volume":"10","author":"Kishore","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103557_b0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/09286580600681339","article-title":"Causal inference in primary open angle glaucoma: specific discussion on intraocular pressure","volume":"13","author":"Bahrami","year":"2006","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.bioorg.2019.103557_b0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2019.103557_b0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103557_b0090","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103557_b0095","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2174\/138161210793429797","article-title":"Carbonic anhydrase inhibition\/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets","volume":"16","author":"Supuran","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2019.103557_b0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2019.103557_b0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1517\/13543776.2012.707646","article-title":"Update on carbonic anhydrase inhibitors: a patent review (2008\u20132011)","volume":"22","author":"Aggarwal","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2019.103557_b0110","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/13543776.16.12.1627","article-title":"Carbonic anhydrase inhibitors and activators and their use in therapy","volume":"16","author":"Scozzafava","year":"2006","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2019.103557_b0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756366.2012.737323","article-title":"Structural annotation of human carbonic anhydrases","volume":"28","author":"Aggarwal","year":"2013","journal-title":"J. Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/14756366.2016.1221826","article-title":"Identification and inhibition of carbonic anhydrases from nematodes","volume":"31","author":"Zolfaghari","year":"2016","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"how many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. of Enz. Inhib. and Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.ki.5002020","article-title":"The role of carbonic anhydrases in renal physiology","volume":"71","author":"Purkerson","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bioorg.2019.103557_b0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103557_b0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/13543776.2012.698264","article-title":"Sulfonamides: a patent review (2008\u20132012)","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2019.103557_b0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1107\/S0907444912002740","article-title":"Beyond the detergent effect: a binding site for sodium dodecyl sulfate (SDS) in mammalian apoferritin","volume":"68","author":"Liu","year":"2012","journal-title":"Acta. Crystallogr. D."},{"key":"10.1016\/j.bioorg.2019.103557_b0150","first-page":"159","article-title":"The cellular physiology of carbonic anhydrases","volume":"2","author":"Breton","year":"2001","journal-title":"JOP. J Pancreas."},{"key":"10.1016\/j.bioorg.2019.103557_b0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3748\/wjg.v11.i2.155","article-title":"Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours","volume":"11","author":"Kivel\u00e4","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2019.103557_b0160","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem Rev."},{"key":"10.1016\/j.bioorg.2019.103557_b0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/prot.340040406","article-title":"Refined structure of human carbonic anhydrase II at 2.0 \u00c5 resolution","volume":"4","author":"Eriksson","year":"1988","journal-title":"Proteins."},{"key":"10.1016\/j.bioorg.2019.103557_b0170","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jmb.2008.11.037","article-title":"Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans","volume":"385","author":"Schlicker","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.103557_b0175","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.biochi.2012.02.013","article-title":"Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii","volume":"94","author":"Alterio","year":"2012","journal-title":"Biochimie."},{"key":"10.1016\/j.bioorg.2019.103557_b0180","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1073\/pnas.0910866107","article-title":"Structural basis of the oxidative activation of the carboxysomal gamma-carbonic anhydrase, CcmM","volume":"107","author":"Pe\u00f1a","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2019.103557_b0185","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/newbio235131a0","article-title":"Crystal structure of human carbonic anhydrase C","volume":"235","author":"Liljas","year":"1972","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.bioorg.2019.103557_b0195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumors as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103557_b0200","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1021\/bi00445a054","article-title":"Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant","volume":"28","author":"Tu","year":"1989","journal-title":"Biochemistry."},{"key":"10.1016\/j.bioorg.2019.103557_b0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/ar00145a005","article-title":"The catalytic mechanism of carbonic anhydrase: implications of a rate-limiting protolysis of water","volume":"21","author":"Silverman","year":"1988","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103557_b0210","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0022-2836(92)90531-N","article-title":"Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes","volume":"227","author":"H\u00e5kansson","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.103557_b0215","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1021\/ja00025a005","article-title":"Unexpected pH-dependent conformation of His-64, the proton shuttle of carbonic anhydrase II","volume":"113","author":"Nair","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103557_b0220","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1021\/ja01167a012","article-title":"Roblin, Heterocyclic sulfonamides as carbonic anhydrase inhibitors","volume":"72","author":"Miller","year":"1950","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103557_b0225","first-page":"272","article-title":"Is cyanate a carbonic anhydrase substrate?, Proteins: Structure","volume":"27","author":"Supuran","year":"1997","journal-title":"Function and Genetics."},{"key":"10.1016\/j.bioorg.2019.103557_b0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BFb0111580","article-title":"Carbonic anhydrase: An insight into the zinc binding site and into the active cavity through metal substitution","volume":"48","author":"Bertini","year":"1982","journal-title":"Struct. Bond."},{"key":"10.1016\/j.bioorg.2019.103557_b0235","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1432-1033.1992.tb17490.x","article-title":"Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions","volume":"210","author":"Mangani","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2019.103557_b0240","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmcl.2009.10.036","article-title":"Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of openangle glaucoma","volume":"19","author":"Steele","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103557_b0245","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/14756366.2011.597749","article-title":"A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without no donating moieties. Mechanism of action and preliminary pharmacology","volume":"27","author":"Fabrizi","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0250","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.bmc.2017.01.032","article-title":"Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors","volume":"25","author":"Alaa Abdel-Aziza","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0255","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.bmc.2017.07.056","article-title":"Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties","volume":"25","author":"Angeli","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0260","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.bmcl.2014.09.076","article-title":"Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds","volume":"24","author":"Alaa Abdel-Aziza","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103557_b0265","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.bmc.2014.01.031","article-title":"Carbonic anhydrase inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties","volume":"22","author":"Sethi","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0270","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1016\/j.bmc.2013.06.035","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety","volume":"21","author":"Sethi","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0275","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/157340607781024447","article-title":"Quantitative structure activity relationship studies of sulfamide derivatives as carbonic anhydrase inhibitor: As Antiglaucoma Agents","volume":"3","author":"Kumar","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0280","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/ci600298r","article-title":"3D QSAR Selectivity Analyses of Carbonic Anhydrase Inhibitors: Insights for the Design of Isozyme Selective Inhibitors","volume":"46","author":"Weber","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2019.103557_b0285","first-page":"6945","article-title":"4-Functionalized 1, 3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII","volume":"24","author":"Ceruso","year":"2014","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0290","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejmech.2004.03.002","article-title":"QSAR study on carbonic anhydrase inhibitors: aromatic\/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents","volume":"39","author":"Agrawal","year":"2004","journal-title":"Euro. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0295","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.bmc.2017.03.017","article-title":"Synthesis and human\/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties","volume":"25","author":"Mohamed","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0300","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/14756366.2017.1367775","article-title":"Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5- trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity","volume":"32","author":"Kumar","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0305","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.03.030","article-title":"Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I II, IV and IX inhibitors","volume":"150","author":"Vats","year":"2018","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0310","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2018.06.021","article-title":"Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I II, IV and IX inhibitors","volume":"8","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0315","doi-asserted-by":"crossref","first-page":"111698","DOI":"10.1016\/j.ejmech.2019.111698","article-title":"Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors","volume":"183","author":"Vats","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0320","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","article-title":"Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations","volume":"59","author":"Nocentini","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0325","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3109\/14756366.2016.1147438","article-title":"Synthesis and carbonic anhydrase I, II., IV and XII inhibitory properties of N-protected amino acid sulfonamide conjugates","volume":"31","author":"K\u00fc\u00e7\u00fckbay","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bmc.2015.11.034","article-title":"Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide\/phthalic anhydride scaffolds","volume":"24","author":"El-Azaba","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0335","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/jm0108202","article-title":"Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties","volume":"45","author":"Scozzafava","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/1475636021000010950","article-title":"Carbonic anhydrase inhibitors: synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties","volume":"17","author":"Casini","year":"2002","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0960-894X(00)00075-5","article-title":"Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties","volume":"10","author":"Renzi","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103557_b0350","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/jm00132a003","article-title":"Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma","volume":"32","author":"Baldwin","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0355","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/jm00037a015","article-title":"Synthesis and carbonic anhydrase inhibitory activity of 4-substituted 2-thiop henesulfonamfdes","volume":"37","author":"Holmes","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756369809028339","article-title":"Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes","volume":"13","author":"Supuran","year":"1998","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2019.103557_b0365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756369809021475","article-title":"Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides - a novel class of intraocular pressure lowering agents","volume":"13","author":"Mincione","year":"1998","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2019.103557_b0370","first-page":"419","article-title":"Carbonic anhydrase inhibitors: novel compounds containing s-nh moieties: sulfenamido-sulfonamides, sulfenimido-sulfonamides and their interaction with isozymes I","volume":"13","author":"Scozzafava","year":"1998","journal-title":"II and IV J. Enzyme Inhib."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103557_b0375","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0968-0896(00)00143-7","article-title":"Carbonic anhydrase inhibitors: sulfonamides incorporating furan-, thiophene- and pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions","volume":"8","author":"Ilies","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0380","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/14756369909030336","article-title":"Carbonic anhydrase inhibitors. water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic\/heterocyclic sulfonamides: is the tail more important than the ring?","volume":"14","author":"Menabuoni","year":"1999","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2019.103557_b0385","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1021\/jm9901879","article-title":"Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl\/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0390","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1021\/jm000296j","article-title":"Carbonic anhydrase inhibitors: perfluoroalkyl\/aryl-substituted derivatives of aromatic\/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0960-894X(00)00722-8","article-title":"Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails of their zinc complexes with powerful topical antiglaucoma properties","volume":"11","author":"Scozzafava","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103557_b0400","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/14756366.2012.727410","article-title":"More effective dithiocarbamate derivatives inhibiting carbonic anhdrases, generated by QSAR and computational design","volume":"28","author":"Avram","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0405","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/acsmedchemlett.7b00387","article-title":"Synthesis of novel selenides bearing benzenesulfonamide moieties as carbonic anhydrase I, II, IV, VII and IX inhibitors","volume":"8","author":"Angeli","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103557_b0410","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bioorg.2018.02.015","article-title":"Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Lolak","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0415","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bioorg.2018.01.031","article-title":"Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors","volume":"77","author":"Mahmood","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0420","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bioorg.2017.12.010","article-title":"First evaluation of organotellurium derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors","volume":"76","author":"Angeli","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0425","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cmdc.201800180","article-title":"Synthesis and Biological Evaluation of 4-sulfamoylphenyl\/sulfocoumarin carboxamides as selective inhibitors of carbonic anhydrase isoforms hCA-II, IX and XII","volume":"13","author":"Angapelly","year":"2018","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0430","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejmech.2018.04.002","article-title":"2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents","volume":"151","author":"Chiaramonte","year":"2018","journal-title":"Euro. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0435","series-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","first-page":"473","article-title":"Carbonic anhydrases as drug targets: general presentation","author":"Supuran","year":"2009"},{"key":"10.1016\/j.bioorg.2019.103557_b0440","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bioorg.2018.10.037","article-title":"4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II\/IX inhibition","volume":"83","author":"Alaa Abdel-Aziza","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0445","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bioorg.2016.12.001","article-title":"Anticancer, Antimicrobial and Carbonic Anhydrase Inhibition Profiles of Novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7- methanoisoindole-1,3(2H)-dione Derivatives","volume":"70","author":"Kocyigit","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103557_b0450","first-page":"350","article-title":"Synthesis and carbonic anhydrase inhibition of tetrabromo chalcone derivatives","volume":"12","author":"Kocyigit","year":"2017","journal-title":"Arch. Pharm. Chem. Life Sci"},{"key":"10.1016\/j.bioorg.2019.103557_b0455","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bioorg.2018.12.035","article-title":"Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and \u03b1-glycosidase inhibitors","volume":"85","author":"Burmaoglu","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103557_b0460","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22261","article-title":"Synthesis and characterization of novel substituted thiophene derivatives and discovery of their carbonic anhydrase and acetylcholinesterase inhibition effects","volume":"33","author":"Cetin","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2019.103557_b0465","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bioorg.2018.10.005","article-title":"Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors","volume":"82","author":"Lolak","year":"2018","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819318255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819318255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:58:02Z","timestamp":1758614282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819318255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":93,"alternative-id":["S0045206819318255"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103557","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103557"}}